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Introduction: Direct visual inspection for cervical cancer screening remains controversial, 
whereas colposcopy-biopsy is considered the gold standard for diagnosis of preneoplastic 
cervical lesions.
Objectives: To determine the rates of cervical intraepithelial neoplasia grade 2 or more and 
of false positives for colposcopy and direct visual inspection.
Materials and methods: Women aged 25-59 underwent direct visual inspection with acetic 
acid (VIA), Lugol’s iodine (VIA-VILI), and colposcopy. Punch biopsies were obtained for all 
positive tests. Using histology as the gold standard, detection and false positive rates were 
compared for VIA, VIA-VILI, and colposcopy (two thresholds). Sensitivity and false positive 
ratios with the corresponding 95% confidence intervals were estimated.
Results: We included 5,011 women in the analysis and we obtained 602 biopsies. Positivity 
rates for colposcopy high-grade and low-grade diagnosis were 1.6% and 10.8%. Positivity 
rates for VIA and VIA-VILI were 7.4% and 9.9%. VIA showed a significantly lower detection 
rate than colposcopy with low-grade diagnosis as the threshold (SR=0.72; 95% CI 0.57-0.91), 
and significantly lower false positive rate (FPR=0.70; 95% CI 0.65-0.76). No differences 
between VIA-VILI and colposcopy low-grade threshold were observed. VIA and VIA-VILI 
showed significantly higher detection and false positive rates than colposcopy high-grade 
threshold. Sensitivity rates for visual inspection decreased with age and false positive rates 
increased. For all age groups, false positive rates for VIA and VIA-VILI were significantly 
higher than colposcopy.
Conclusions: Detection rates for VIA-VILI similar to colposcopy low-grade threshold 
represent a chance to reduce cervical cancer mortality through see-and-treat approaches 
among women with limited access to health care. Lower detection rates suggest reviewing 
high-grade colposcopy findings as the threshold for biopsy in certain settings.
Key words: Uterine cervical neoplasms; mass screening; sensitivity and specificity; 
colposcopy; Colombia.
Técnicas visuales en la tamización del cáncer de cuello uterino
Introducción. La inspección visual directa para la tamización del cáncer cervical sigue 
siendo controversial, mientras que la colposcopia y la biopsia siguen considerándose como 
métodos de referencia para diagnosticar lesiones cervicales precancerosas.
Objetivo. Determinar las tasas de detección de neoplasia intraepitelial cervical de grado 2 
y de los falsos positivos en la colposcopia y la inspección visual directa.
Materiales y métodos. Se seleccionaron mujeres de 25 a 59 años sometidas a citología 
convencional, inspección visual directa con ácido acético y disolución de Lugol y 
colposcopia. Se practicó biopsia en todas las pruebas positivas. Utilizando la histología 
como el medio de verificación de referencia, se compararon las tasas de detección y de 
falsos positivos de cada prueba. Se estimaron las razones de sensibilidad y de falsos 
positivos con los correspondientes intervalos de confianza.
Resultados. Se incluyeron 5.011 mujeres. Las colposcopias positivas de alto y bajo 
grado correspondieron a 1,6 y 10,8 %, respectivamente. La inspección visual directa con 
ácido acético y solución yodada de Lugol fue positiva en 7,4 y 9,9 %, respectivamente. 
La inspección visual directa con ácido acético tuvo tasas de detección y falsos positivos 
significativamente menores que la coloscopia con umbral de bajo grado (razón de 
sensibilidad: 0,72; IC95% 0,57-0,91; razón de falsos positivos: 0,70; CI95% 0,65-0,76); no 
hubo diferencias entre la inspección visual directa con solución yodada de Lugol y la 
colposcopia con dicho umbral. Las tasas de detección y de falsos positivos de los dos tipos 
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de inspección visual fueron significativamente más altas que las de la colposcopia con el 
umbral de alto grado. Las tasas de detección de la inspección visual disminuyeron con la 
edad y las de falsos positivos aumentaron.
Conclusiones: Las tasas de detección similares para la inspección visual directa con 
ácido acético o con solución yodada de Lugol y la colposcopia con umbral de bajo grado 
representan una oportunidad para reducir la mortalidad por cáncer de cuello uterino 
cuando el acceso a los servicios de salud es limitado. Las tasas de detección más bajas 
para la colposcopia con umbral de alto grado sugieren la necesidad de revisar dicho 
umbral en ciertos entornos.
Palabras clave: neoplasias del cuello uterino; tamizaje masivo; sensibilidad y 
especificidad; colposcopia; Colombia.
Cervical cancer persists as a relevant cause of cancer mortality among 
women from developing countries where 83.1% of cases and 85.5% of 
deaths occur (1). From 2007 to 2011, 4,462 cases and 1,861 deaths due to 
this cancer per year were estimated in Colombia and it remains a leading 
cause of cancer mortality among women (2). 
Cervical cytology has been the main strategy for cervical cancer early 
detection. After the introduction of massive screening, a reduction of invasive 
cervical cancer incidence and mortality was observed in most developed 
countries (3); conversely, conventional cytology has not reduced cervical 
cancer mortality in the majority of developing nations. Cytology is a highly 
specific technique, however, it is only moderately sensitive (about 50%) (4); 
therefore, cytology-based screening programs require frequent examinations 
and multiple visits to healthcare centers in order to complete the entire 
process for screening, diagnosis, and treatment of cervical intraepithelial 
neoplasia (CIN). The above mentioned factors, combined with limited access 
to healthcare services, have been cited as the main restraints on successful 
cervical cancer screening in low- and middle-income countries (5).
Alternative approaches have been evaluated as a means of improving 
screening performance. HPV tests have demonstrated high sensitivity 
(about 90%) but no impact on the number of visits for follow-up of screened 
women with positive results (4,5). Recently, a new generation of HPV tests 
has been developed to provide rapid results allowing for the possibility 
of conducting immediate treatment of preneoplastic lesions (6); however, 
strategies for immediate triage to select women for treatment during the 
same visit are still under elucidation.
Direct visual inspection with acetic acid (VIA) or Lugol’s iodine (VILI) 
has been evaluated in several studies in developing countries (7). The 
main advantage of VIA and VILI is the immediate report that allows for 
treatment of preneoplastic lesions during the same visit thereby reducing 
the difficulties for follow-up of screened women with positive results. VIA 
and VILI have been compared with conventional cytology and HPV tests 
showing higher sensitivity than the former but lower than the latter (4,7). 
Moreover, the evaluation of VIA with magnification lenses (VIAM) has 
revealed no improvement in sensitivity or specificity compared with naked-
eye visual inspection (8).
On the other hand, colposcopy provides a potent magnified visual evaluation 
of the cervix with the help of acetic acid and Lugol’s iodine. The use of colposcopy 
for the diagnosis of cervical lesions and the orientation of cervical biopsies 
is widely accepted and studies of diagnostic accuracy in this field generally 
apply colposcopy (and oriented biopsy) as the reference standard. However, 
colposcopy as a screening test has reported only moderate proficiency (8;9).
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The aim of our study was to compare the data on colposcopy and direct 
visual inspection proficiency as screening tools in see-and-treat scenarios for 
CIN2-3 or cancer detection in a Latin American population.
Materials and methods
A diagnostic accuracy study was conducted with 5,011 women from three 
low-income districts in Bogotá, Colombia. The protocol was approved by the 
Ethical Committee at the Instituto Nacional de Cancerología of Colombia. 
The detailed methodology has been described elsewhere (10). Women 
were consecutively recruited at primary care centers. In one visit, each 
woman underwent consecutive conventional cytology, VIA, VILI, and 
colposcopy. Both VIA and VILI had the same provider, a nurse, who had 
taken a one-week training course. Colposcopy was performed by expert 
gynecologists from the Hospital de San José. Interpreters for conventional 
cytology, VIA-VILI, and colposcopy were blinded from each other and punch 
biopsies were obtained independently for any positive VIA, VIA-VILI or 
colposcopy (Reid index ≥1) results. If cytology reported a high-grade lesion 
(high-grade squamous intraepithelial lesion, HSIL) or more, and the visual 
techniques were negative, the patient underwent a second colposcopy.
Positive VIA corresponded to acetowhite growths or definite lesions close 
to the squamocolumnar junction. Positive VILI corresponded to yellow non-
uptake iodine areas close to the squamocolumnar junction. For comparative 
purposes, we defined two colposcopy thresholds: Low-grade CIN and high-
grade CIN diagnoses (Reid index: 0-2 and 3-8, respectively) (10).
Based on the independent collection of histological samples for any 
positive visual technique, the biopsy was assumed to be the gold standard. 
Excluding colposcopy from the gold standard induces a verification bias 
since only screened women with positive results underwent biopsy and, thus, 
neither sensitivity nor specificity could be directly estimated for comparative 
purposes. To tackle this problem, we compared detection rates and false 
positive rates conducting the analysis according to Sullivan (table 1) (11).
The detection rate (DR) corresponds to the joint probability for the test 
and the gold standard to be positive (DR = P(Y=1, D=1)), false positives 
correspond to the joint probability for the test to be positive and the gold 
standard to be negative (FP = P(D=0,Y=1)), and the disease prevalence 
Table 1. Framework for screening tests analysis 
To compare colposcopy with direct visual inspection we did not assume colposcopy as the 
gold standard; consequently, we solved the verification bias by comparing detection and 
false positive rates between the two techniques according to Sullivan (11). Detection rates 
correspond to the product of multiplying test sensitivity by the prevalence of disease and 
false-positive rates correspond to the proportion of false-positive results multiplied by the 
complement of disease prevalence.
Biopsy
Positive (D=1) Negative (D=0)
Test A negative 
(YA=0)
Test A positive 
(YA=1)
Test A negative 
(YA=0)
Test A positive 
(YA=1)
Test B negative (YB=0)
Test B positive (YB=1)
?
c
b
d
?
g
f
h
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corresponds to the probability for the gold standard to be positive (P(D=1)). 
Therefore, the DR for a given test (A or B) corresponds to the product 
of multiplying its sensitivity by the prevalence of the disease (DRA = 
((b+d)/(c+d+b+?)) * ((c+d+b+?)/N) in table 1), FP for a given test (A or 
B) corresponds to its proportion of false positive results multiplied by the 
complement of the disease prevalence (FPA = ((f+h)/(g+h+f+?))*((g+h+f+?)/N) 
in table 1). Since our study had a parallel design, the prevalence of the 
disease was the same for all tests allowing for direct comparison.
Accordingly, we compared colposcopy with VIA and VIA-VILI by 
determining sensitivity ratios (SR=DRVIA/DRColpo and SR=DRVIA-VILI/DRColpo) 
and false positive ratios (FPR=FPVIA/FPColpo and FPR=FPVIA-VILI/FPColpo). 
A comparison of VIA and VIA-VILI had already been reported estimating 
sensitivity and specificity for both tests when using colposcopy and biopsy as 
the gold standard (10). The biopsy was considered positive with a report of 
CIN grade 2 or more.
The variance for sensitivity ratios and false positive ratios was estimated, 
and the corresponding 95% confidence intervals reported: Var (log SR) =  
(DRA + DRB - 2SR)/(N DRA* DRB) Var (log FPR) =  (FPA + FPB - 2FPR)/(N FPA* 
FPB), where SR corresponds to the joint probability for both tests and the 
gold standard to be positive (P (YA = YB =1, D=1)), and FPR corresponds to 
the joint probability for both tests to be positive and the gold standard to be 
negative (P(YA=YB=1,D=0)). The analysis was carried out with Stata 13.0™.
Results
In total, 54 women were excluded for various reasons (12) and 4,957 
underwent screening from whom 602 biopsies were obtained (figure 1). The 
average age was 39.2 years (range: 25-59). Positivity rates for colposcopy 
were 1.6% when using the high-grade CIN threshold, and 10.8% for the 
low-grade CIN threshold. Positivity rates for VIA and VIA-VILI were 7.4% and 
9.9%, respectively.
VIA revealed a significantly lower detection rate than colposcopy low-
grade CIN threshold (SR 0.72, 95%CI: 0.57-0.91) and simultaneously 
reported a significantly lower false-positive rate (FPR 0.70, 95%CI 0.65-0.76) 
(table 2). No significant differences between VIA-VILI and colposcopy were 
observed when using this colposcopy threshold.
Using the high-grade CIN threshold for colposcopy, both VIA and VIA-VILI 
showed significantly higher detection and false positive rates (table 2). Detection 
rate for VIA-VILI was twice the correspondent detection rate for colposcopy and 
its false positives were eight times higher than those for colposcopy.
Sensitivity rates for VIA and VIA-VILI decreased with age (figure 2). 
Between ages 25 and 49, VIA-VILI showed higher sensitivity rates than VIA 
alone when compared to colposcopy but without significant differences. Both 
tests had significantly higher detection rates than colposcopy between ages 
30-39 (SRVIA/Colpo2.4, CI95%: 1.3-4.2; and SRVIA-VILI/Colpo2.8, CI95%: 1.5-5.0). No 
major changes with age were observed for sensitivity rates when using the 
low-grade CIN colposcopy threshold.
The false positive rates for VIA and VIA-VILI increased with age, being 
particularly high over age 50 (figure 2). For all age groups, the VIA and VIA-
VILI probability of false positives was significantly higher than colposcopy. 
Between ages 30-59, VIA-VILI revealed higher sensitivity rates than VIA alone 
69
Biomédica 2019;39:65-74 Visual techniques for cervical cancer screening
Table 2. Detection and false positive rates contrasting VIA, VIA-VILI, and colposcopy
Figure 1. Study flow chart
SR 95% Cl FPr 95% Cl
Colposcopy low grade threshold
VIA/Colposcopy
VIA-VILI/Colposcopy
Colposcopy low grade threshold
VIA/Colposcopy
VIA-VILI/Colposcopy
0.72
0.92
1.57
2.00
0.57-0.91
0.75-1.12
1.10-2.23
1.41-2.83
0.70
0.96
5.75
7.88
0.65-0.76
0.91-1.01
4.46-7.41
6.12-10.13
Test Colposcopy LG Colposcopy HG+ VIA VIA-VILI
Positive women 454 80 368 493
VIA: Visual inspection with acetic acid; VILI: Visual inspection with Lugol iodine; SR: Sensitivity ratio; 
FPR: False positive ratio
VIA: Visual inspection with acetic acid; VILI: Visual inspection with Lugol iodine;  LG: Low grade; HG: High grade
* VIA and VILI 45; VIA and colposcopy 4; VILI and colposcopy 103; VIA, VILI, and colposcopy 312; colposcopic 
evaluation without previous screening report 
** Initial colposcopic evaluation negative with a second colposcopic evaluation after low-grade lesion reported 
on conventional cytology. They were included to integrate the histopathology evaluation in the gold standard 
without considering them for assessment of colposcopy detection or false positive rates. The figure describes 
specific test positivity.
Women 25-59
(n=4,957)
VIA, VILI, or
colposcopy* 464
27
2
109
VIA
VILI
Colposcopy**
6024,355
All tests negative All tests positive
when compared with colposcopy but without significant differences. For the 
low-grade colposcopy threshold no major changes with age were observed; 
nevertheless, VIA had a significantly lower false-positive rate than colposcopy 
in all age groups.
 Discussion
Several studies have evaluated alternatives to conventional cytology 
attempting to improve the performance of screening programs in developing 
countries and the accuracy of cervical cancer screening tests is currently 
a topic of major discussion. In addition, low access to regular healthcare 
is observed as one of the major restraints for such settings inducing low 
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screening adherence and follow-up of screened women with positive results; 
accordingly, see-and-treat approaches have been proposed as a promising 
alternative to reduce cervical cancer mortality in low-income regions (8). 
Colposcopy and directed biopsy are considered the gold standard for 
CIN diagnosis. High specificity is the principal advantage of colposcopy and 
guidance for the diagnostic biopsy is frequently highlighted as the principal 
role of colposcopy; moreover, earlier data revealed an 83-84% agreement for 
CIN2+ diagnosis between colposcopy guided biopsies and loop excision (12).
Although direct visual inspection for cervical cancer screening uses the 
same technical principles as colposcopy, it is still controversial. The main 
concerns about VIA and VILI are their low specificity and reliability (7). Indeed, 
several studies have shown significantly lower specificity for direct visual 
inspection than for conventional cytology but, simultaneously, they have 
demonstrated a similar or higher sensitivity (particularly for VILI) (7).
Taking into account the advantages and restraints of visual screening 
techniques means that careful application is paramount in areas where 
high cervical cancer risk and low access to healthcare services sustains its 
greatest suitability, spaced out from areas with proper access to healthcare 
where women can seek screening, diagnosis, and treatment in several visits 
(10). Hence, the availability of immediate results allowing for immediate 
treatment, the low cost, and the implementation feasibility of visual screening 
in the former scenarios stress the need for an unbiased appraisal. 
Figure 2. Sensitivity ratios and false positive ratios according to age group
VIA: Visual inspection with acetic acid; VILI: Visual inspection with Lugol iodine;  LG: Low grade; HG: High grade
25-29
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Our study is one of the first to compare colposcopy, VIA, and VILI in Latin 
America where many areas lack the necessary infrastructure and resources 
to maintain an organized screening program based on Pap-smear (several 
visits). The results show higher detection rates for VIA and VIA-VILI over 
colposcopy when the high-grade CIN colposcopic diagnosis is used as the 
positive threshold but the difference disappears if the threshold for colposcopy 
is changed to low-grade CIN diagnosis; for this latter cutoff point, colposcopy 
detects more CIN2+ than VIA alone.
These data revealed a lack of correlation between high-grade colposcopic 
appearance and CIN2+ diagnosis. The use of colposcopy without the 
guidance of a previous test (screening) has been debatable. Blinded 
colposcopies have shown lower accuracy than diagnostic colposcopies 
after a positive screening test (8,13,14). In addition, previous reports have 
demonstrated that colposcopy sensitivity increases considerably when 
taking additional biopsies to those guided by the colposcopic appearance 
of high-grade CIN (15,16). The detection of CIN2+ increases up to 37% 
when additional biopsies are obtained (15,17) and this increase has been 
demonstrated to be determined by the number of biopsies, regardless of the 
provider. The reason for the expanded detection is apparently related to the 
small size of several CIN2+ lesions because a correlation between false-
negative colposcopy and thinner lesions has been observed (14,18-20).
The present study results corroborate the high specificity of colposcopy 
but this goes together with a lower detection rate suggesting that colposcopy 
diagnosis (low-grade or high-grade) merits careful review as the basis for 
orienting biopsies. These findings highlight the limitations of visual techniques 
for screening purposes (with or without magnification), but they also reveal to 
some extent the need for improving CIN diagnostic methods.
VIA-VILI reproduces the colposcopic procedure (without magnification) and 
certain studies have shown no gain when adding magnification to direct visual 
inspection with acetic acid (8). However, colposcopy provides considerably 
more detailed information on the cervical epithelium leading to more precise 
CIN diagnoses as demonstrated by its lower false positive rates. Furthermore, a 
meta-analysis showed a high correlation between direct VIA or VILI (higher for 
VILI) and colposcopy used as the gold standard (7) confirming our results where 
VIA-VILI had no significant differences with colposcopy low-grade threshold. 
On the other hand, the false positive rates showed an opposite tendency with 
higher values for VIA and VIA-VILI when compared to colposcopy high-grade 
CIN threshold but, again, the difference disappeared for the low-grade threshold 
highlighting the fact that the accuracy of VIA-VILI was equivalent to colposcopy 
low-grade CIN threshold for both detection and false positive rates.
The analysis according to age groups showed no major changes in 
sensitivity and false positive rates for colposcopy low-grade CIN threshold. 
Conversely, for the high-grade CIN threshold, colposcopy proved to be more 
specific across age groups than either VIA or VIA-VILI because there were no 
differences in detection rates but false positive rates were significantly higher. 
This latter observation is particularly relevant in postmenopausal women 
(over age 50) and the variation was greater for VIA alone since the detection 
rates for ages 40 and over significantly decreased. Previous studies on visual 
inspection have found lower positive rates in postmenopausal women due to 
the characteristics of the transformation zone for this age group (7-10); the 
addition of high false positive rates might suggest a contraindication for direct 
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visual inspection among women over fifty. A higher false positive rate induces 
higher overtreatment in see-and-treat scenarios; yet, overtreatment with 
ablative methods do have a low rate of side effects (21).
Additional limitations of visual screening are low reproducibility and lack 
of experience in everyday settings. The existing information shows extensive 
worldwide variation for direct visual inspection among studies (7), which 
indicates that the training level, the experience in carrying out the tests, and the 
regular evaluation of providers are key components for these techniques as it 
would be for colposcopic screening. Furthermore, in Latin America, colposcopy 
is provided only by trained gynecologists, a resource scarcely available in areas 
with low access to health care; however, nurse colposcopy extends over many 
developed and developing countries. Additionally, accuracy of colposcopy and 
visual inspection has been shown to be similar when delivered by nurses or 
physicians but dependent upon the level of training and expertise (22,23).
Despite the aforementioned restraints, a clinical trial revealed a reduction 
in cervical cancer mortality of around 37% using VIA and immediate treatment 
(same visit) (21), but this reduction could not be reproduced in a second trial 
where the treatment was provided during a subsequent visit after colposcopic 
evaluation thus resulting in a lower treatment rate (24). In a second study, 
only HPV tests achieved a significant reduction in cervical cancer mortality 
demonstrating the relevance of highly sensitive tests in which only a few 
contacts for the target population are expected. Concordantly, economic 
evaluations for developing countries have reported better cost-effectiveness 
ratios for screening and treatment in one visit, as well as a progressive reduction 
in screening proficiency when the number of visits is incremented (25).
VIA, and particularly VIA-VILI, have proven higher sensitivity than cytology (7). 
In this sense, our study showed they have similar detection rates than colposcopy 
using the low-grade diagnosis as the threshold, which opens a window for the 
use of these techniques as screening methods in the context of see-and-treat 
approaches aimed at reducing the number of visits. Accordingly, if rapid HPV 
tests capable of producing immediate results were available, both techniques 
used as reflex or triage tests for immediate treatment represent the chance for 
reducing cervical cancer mortality for underserved women where see-and-treat is 
a more suitable approach than screening programs based on multiple visits.
Although cervical cancer screening studies in developing countries 
frequently have a verification bias, a proper analysis could lead to accurate 
comparisons between screening alternatives avoiding underutilization of 
available data. Visual techniques could help reducing cervical cancer mortality 
by decreasing the number of visits between screening and treatment. In this 
context, VIA-VILI and colposcopy with low-grade threshold were equivalent 
and reported acceptable proficiency for screening purposes.
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